Group I (Pack Health Program) for Breast Carcinoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
M D Anderson Cancer Center, Houston, TX
Breast Carcinoma+1 More
Supportive Care - Procedure
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial studies how well an electronic (e)-health support program, called the PACK Health Program, supports patient reported symptoms in newly diagnosed patients with breast cancer. PACK Health offers a symptom management program involving both interpersonal interaction, as well as e-modules for patients diagnosed with cancer to better manage pain, fatigue, depression, anxiety, and to navigate care more effectively through e-health coaching and tools. Participating in the PACK Health Program may support breast cancer patients' reported side effects and experience of care during chemotherapy treatment and may ultimately improve overall health.

Eligible Conditions

  • Breast Carcinoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline up to 3 months

Month 3
Impact of electronic (e)-health support program on patient reported outcomes

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Group II (standard of care support services)
1 of 2
Group I (Pack Health Program)
1 of 2
Active Control
Experimental Treatment

440 Total Participants · 2 Treatment Groups

Primary Treatment: Group I (Pack Health Program) · No Placebo Group · N/A

Group I (Pack Health Program)Experimental Group · 2 Interventions: Supportive Care, Questionnaire Administration · Intervention Types: Procedure, Other
Group II (standard of care support services)ActiveComparator Group · 2 Interventions: Supportive Care, Questionnaire Administration · Intervention Types: Procedure, Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Supportive Care
2013
Completed Phase 2
~720

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline up to 3 months
Closest Location: M D Anderson Cancer Center · Houston, TX
Photo of Houston  1Photo of Houston  2Photo of Houston  3
2003First Recorded Clinical Trial
33 TrialsResearching Breast Carcinoma
460 CompletedClinical Trials

Eligibility Criteria

Age 18+ · Female Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have access to a mobile phone, a landline phone, a computer, or another device with the capacity to receive calls, texts, or e-mails.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.